Seventh International Congress on Targeted Therapies in Cancer
Renaissance Mayflower Hotel
Washington, DC
August 22-24, 2008
Alex Adjei, MD, PhD
Professor and Chair, Department of Medicine
Senior Vice President, Clinical Research
Roswell Park Cancer Institute
Buffalo, NY
Anthony Tolcher, MD
Director, Clinical Research
South Texas Accelerated Research Therapeutics
Clinical Professor
Division of Medicine/Oncology
The University of Texas Health
Science Center at San Antonio
San Antonio, TX
Howard A. Burris III, MD, FACP
Chief Medical Officer
Director, Drug Development
Sarah Cannon Research Institute
Associate
Tennessee Oncology, PLLC
Nashville, TN
Mark Davis, PhD
Warren and Katharine Schlinger Professor
of Chemical Engineering
California Institute of Technology
Pasadena, CA
Daniel J. DeAngelo, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Adult Leukemia Program
Dana-Farber Cancer Institute
Boston, MA
Mary L. (Nora) Disis, MD
Associate Dean, Translational Science
Professor
School of Medicine
Division of Oncology
University of Washington
Member
Fred Hutchinson Cancer research Center
Seattle, WA
Eric Furfine, PhD
Senior Vice President
Research and Preclinical Development
Adnexus Therapeutics
Waltham, MA
Michael S. Gordon, MD
Premiere Oncology of Arizona
Associate Professor of Clinical Medicine
The University of Arizona College of Medicine
Scottsdale, AZ
Lyndsay Harris, MD
Associate Professor of Medicine
Director, Breast Cancer Disease Program
Yale University School of Medicine
Associate Clinical Professor
Yale University School of Nursing
New Haven, CT
Ivan Horak, MD, FACP
Chief Scientific Officer
Executive Vice President, Research
and Development
Enzon Pharmaceuticals, Inc.
Piscataway, NJ
Herbert Hurwitz, MD
Associate Professor of Medicine
Duke University Medical Center
Durham, NC
Craig Jordan, PhD
Associate Professor of Medicine
James P. Wilmot Cancer Center
University of Rochester Medical Center
Rochester, NY
John Kirkwood, MD
Professor of Medicine and Dermatology
Vice Chairman, Clinical Research
Department of Medicine
The University of Pittsburgh School of Medicine
Director, Melanoma and Skin Cancer Program
The University of Pittsburgh Cancer Institute
Pittsburgh, PA
Thomas Lin, MD, PhD
Associate Professor of Internal Medicine
Division of Hematology and Oncology
The Ohio State University
Columbus, OH
Patricia LoRusso, DO
Director, Phase I Clinical Trials Program
Barbara Ann Karmanos Cancer Institute
Professor of Medicine
Division of Hematology and Oncology
Wayne State University School of Medicine
Detroit, MI
Gordon Mills, MD, PhD
Chair, Department of Systems Biology
Professor of Medicine
Division of Cancer Medicine
Ann Rife Cox Chair in Gynecology
The University of Texas M. D. Anderson Cancer Center
Houston, TX
Edith P. Mitchell, MD, FACP
Clinical Professor of Medicine and Medical Oncology
Program Leader, Gastrointestinal Oncology
Department of Medical Oncology
Associate Director, Diversity Programs
Kimmel Cancer Center
Thomas Jefferson University Hospital
Philadelphia, PA
Shanu Modi, MD
Assistant Member, Breast Cancer Medicine Service
Memorial Sloan-Kettering Cancer Center
New York, NY
William Munger, PhD
Executive Director, Technology and Program Management
Curis, Inc.
Cambridge, MA
Nevin Murray, MD
Clinical Professor of Medicine
University of British Columbia
Medical Oncologist
British Columbia Cancer Agency
Vancouver, British Columbia, Canada
Ramesh K. Ramanathan, MD
Director, GI Oncology Program
Scottsdale Clinical Research Institute & TGen
Scottsdale, AZ
Clinical Professor of Medicine
College of Medicine
The University of Arizona at Phoenix
Phoenix, AZ
Elizabeth A. Repasky, PhD
William Huebsch Professorship of Immunology
Department of Immunology
Roswell Park Cancer Institute
Buffalo, NY
Charles Rudin, MD
Associate Professor and Director, Lung Cancer Therapeutics Program
Co-Director, Upper Aerodigestive Cancer Program
Associate Director, Clinical Research
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, MD
Edward Sausville, MD, PhD, FACP
Professor, Department of Medicine
Adjunct Professor, Department of Pharmacology and Experimental Therapeutics
University of Maryland School of Medicine
Affiliate Professor, Department of Pharmaceutical Sciences
University of Maryland School of Pharmacy
Associate Director, Clinical Research
University of Maryland Greenebaum Cancer Center
Baltimore, MD
David Sidransky, MD
Director and Professor, Head and Neck Cancer Research Department
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, MD
Chris Takimoto, MD, PhD, FACP
Senior Director, Translational Medicine
Ortho Biotech Oncology R&D/Centocor R&D, Inc.
Radnor, PA
Drew Torigian, MD
Assistant Professor of Radiology
Department of Radiology
University of Pennsylvania School of Medicine
Philadelphia, PA
Louis M. Weiner, MD
Director, Lombardi Comprehensive Cancer Center
Francis L. and Charlotte G. Gragnani Chair and Professor
Department of Oncology
Georgetown University Medical Center
Washington, DC
John J. Wright, MD, PhD
Senior Clinical Investigator
Investigational Drug Branch
Cancer Therapy Evaluation Program
National Cancer Institute, National Institutes of Health
Bethesda, MD
Douglas Yee, MD
Director, Masonic Cancer Center
Program Co-Leader, Women’s Cancer Research Program
Professor
Departments of Medicine and Pharmacology
University of Minnesota
Minneapolis, MN
An educational grant for this activity was provided by: